Eli Lil­ly's re­cent­ly re­called glucagon kits were pro­duced at trou­bled In­di­anapo­lis site — re­port

4 years ago
Manufacturing

Schrödinger teams up with MD An­der­son on WEE1 in­hibitor pro­gram; Amid JAK safe­ty con­cerns, Ab­b­Vie touts new da­ta for ...

4 years ago
News Briefing

Bay­er drops $460M in­to con­tra­cep­tive man­u­fac­tur­ing sites with the Unit­ed Na­tion­s' back­ing

4 years ago
Manufacturing

Or­biMed's TKI play makes its Nas­daq de­but as The­seus prices IPO

4 years ago
Financing

Catal­ent opens newest clin­i­cal sup­ply site in Japan, ex­pand­ing its foot­print in the Pa­cif­ic Rim

4 years ago
Manufacturing

Biden's choice for FDA may be a wild card as top can­di­date says she's not in the run­ning

4 years ago
FDA+

Bris­tol My­er­s' TYK2 drug bombs ul­cer­a­tive col­i­tis test, but hopes are still high with pso­ri­a­sis fil­ing on deck

4 years ago
R&D

Em­bold­ened by a pos­i­tive PhI­II, No­var­tis steers a late-stage BTK in­hibitor in­to a piv­otal MS tri­al

4 years ago
R&D

As con­ti­nen­t's vac­ci­na­tion rate sits be­low 5%, Mod­er­na an­nounces in­vest­ment in mR­NA man­u­fac­tur­ing in Africa

4 years ago
Deals
Coronavirus

Sanofi, Mod­er­na beef up the case for giv­ing flu, Covid-19 vac­cines to el­der­ly in the same vis­it

4 years ago
R&D
Coronavirus

Sci­ence 37 takes the SPAC short­cut to Nas­daq, land­ing a $235M wind­fall for its push on de­cen­tral­ized tri­als

4 years ago
Deals

With a fresh $75M, Michael Ehler­s' lat­est take on non-vi­ral gene ther­a­py is ready for take­off

4 years ago
Financing

In 'his­toric' pub­lic health step, WHO ful­ly en­dors­es Glax­o­SmithK­line's malar­ia shot

4 years ago
R&D

Tiny play­er picks up $30M to go af­ter CAR-T's biggest chal­lenges

4 years ago
Financing
Startups

ARCH un­veils its Re­al­ly Big Neu­ro­science Com­pa­ny with $500M, an Am­gen deal and eyes on de­pres­sion, Alzheimer's and a ...

4 years ago
Financing
Startups

RA Cap­i­tal kicks off third VC fund as Pe­ter Kolchin­sky and Ra­jeev Shah bank $880M

4 years ago
Financing

FDA+ roundup: Sen. Burr on strength­en­ing FDA's readi­ness; ICH guide­line adop­tion; Long­time FDA lawyer re­tires and ...

4 years ago
FDA+

Two decades af­ter dis­cov­er­ing a new way to con­struct mol­e­cules, David MacMil­lan and Ben­jamin List win No­bel Prize

4 years ago
People

Ae­tion to col­lab­o­rate with UK's NICE on RWE; 4D's cys­tic fi­bro­sis gene ther­a­py cleared for clin­i­cal tri­als

4 years ago
News Briefing

UBS wants to make an 'im­pact' with a new fund, shelling out $650M to join MPM

4 years ago
Financing

Break­ing: Pfiz­er de­vel­op­ment chief Rod MacKen­zie is re­tir­ing af­ter a lengthy ca­reer capped by his­toric suc­cess

4 years ago
People

A short-sell at­tack sends Ginkgo's share price spin­ning, un­der­scor­ing in­vestors' con­cerns over syn­bio field

4 years ago
Pharma

FDA of­fers sup­port for Takeda's po­ten­tial cy­tomegalovirus drug ahead of ad­comm

4 years ago
Pharma
FDA+

Is the biotech boom start­ing to fade? The roar­ing ‘20s starts to look a lit­tle fa­tigued. Plus: Top 5 deals, IPOs, ...

4 years ago
Deals
Bioregnum
First page Previous page 630631632633634635636 Next page Last page
A service from the Financial Times